Forbion Capital Partners
34 portfolio companies · 3 on the map · $360.9M raised · 3 cities
Portfolio map
3 Forbion Capital Partners portfolio companies on the map.
Portfolio companies

Milestone Pharmaceuticals
Montreal
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Biotechnology Research$360.9MEst. 2007
uniQure
Amsterdam
uniQure is focused on the research and early development of human gene-based therapies.
Biotechnology ResearchPublicEst. 1998
MapLight Therapeutics
Redwood City
Maplight is a biopharmaceutical company that discovers and develops novel therapeutics for central nervous system disorders, with a focus on bringing new treatments to patients.
BiotechnologySeries DEst. 2018
More portfolio companies
30 more Forbion Capital Partners investments we track beyond the map — 34 tracked in total.
enGeneVancouver · Post-IPO Equity
AAVantgarde BioMilano · Series B
CatalYmPlanegg · Series D
AzafarosLeiden · Series B
Protego BiopharmaSan Diego · Series B
Verdiva BioLondon · Series A
argenxBoston · Series B
AnaveonBottmingen · Series B
SynOx TherapeuticsDublin · Series B
AIRNACambridge · Series B
InsmedBridgewater · Post-IPO Equity
Marea TherapeuticsSan Francisco · Series B
Noema PharmaBasel · Series B
Seamless TherapeuticsDresden · Seed
Replimune GroupWoburn · Series B
Complement TherapeuticsLondon · Series A
Pheon TherapeuticsLondon · Series B
Mariana OncologyWatertown · Series B
PrileniaHerzliya · Series B
F2GManchester · Private Equity
Genetix Biotherapeutics Inc.Somerville · Series D
Aiolos BioSan Francisco · Series A
OMEICOS TherapeuticsBerlin · Series C
Bicycle TherapeuticsCambridge · Post-IPO Equity
Tessellate BIONaarden · Seed
MitralignTewksbury · Series D
RigontecMartinsried · Series A
Allecra TherapeuticsWeil Am Rhein · Series B
BioVexOxton · Venture
Oxyrane UKManchester · Series D
Portfolio map
3 Forbion Capital Partners portfolio companies on the map.